- Home
- ARI vs CDNA Comparison
ARI vs CDNA Comparison
Compare ARI & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARI
- CDNA
- Stock Information
- Founded
- ARI 2009
- CDNA 1998
- Country
- ARI United States
- CDNA United States
- Employees
- ARI N/A
- CDNA N/A
- Industry
- ARI Real Estate Investment Trusts
- CDNA Medical Specialities
- Sector
- ARI Real Estate
- CDNA Health Care
- Exchange
- ARI Nasdaq
- CDNA Nasdaq
- Market Cap
- ARI 1.2B
- CDNA 1.1B
- IPO Year
- ARI 2009
- CDNA 2014
- Fundamental
- Price
- ARI $9.49
- CDNA $18.39
- Analyst Decision
- ARI Hold
- CDNA Buy
- Analyst Count
- ARI 4
- CDNA 8
- Target Price
- ARI $9.08
- CDNA $29.43
- AVG Volume (30 Days)
- ARI 1.0M
- CDNA 628.1K
- Earning Date
- ARI 04-28-2025
- CDNA 05-08-2025
- Dividend Yield
- ARI 10.58%
- CDNA N/A
- EPS Growth
- ARI N/A
- CDNA N/A
- EPS
- ARI N/A
- CDNA 0.93
- Revenue
- ARI $147,887,000.00
- CDNA $333,785,000.00
- Revenue This Year
- ARI $29.85
- CDNA $13.33
- Revenue Next Year
- ARI $1.28
- CDNA $15.07
- P/E Ratio
- ARI N/A
- CDNA $19.51
- Revenue Growth
- ARI N/A
- CDNA 19.07
- 52 Week Low
- ARI $8.44
- CDNA $7.42
- 52 Week High
- ARI $11.20
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- ARI 35.76
- CDNA 42.77
- Support Level
- ARI $9.32
- CDNA $16.98
- Resistance Level
- ARI $9.69
- CDNA $20.00
- Average True Range (ATR)
- ARI 0.18
- CDNA 0.82
- MACD
- ARI -0.07
- CDNA 0.05
- Stochastic Oscillator
- ARI 20.89
- CDNA 46.69
About ARI Apollo Commercial Real Estate Finance Inc
Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.